Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Oct 1;32(6):taaf047.
doi: 10.1093/jtm/taaf047.

Efficacy of bismuth subsalicylate on the prevention of travellers' diarrhoea, 2018-2023

Affiliations
Randomized Controlled Trial

Efficacy of bismuth subsalicylate on the prevention of travellers' diarrhoea, 2018-2023

Kristina M Angelo et al. J Travel Med. .

Abstract

Background: Travellers' diarrhoea (TD) is the most common travel-related illness. Bismuth subsalicylate (BSS) is indicated for the treatment of TD. BSS is also used off-label for the prevention of TD, based on studies from the 1980s indicating TD protection; however, these studies have limitations. The objective of this study was to determine the efficacy of BSS in the prevention of TD.

Methods: This study was a prospective, double-blinded, placebo-controlled, randomized clinical trial (NCT03535272) with two arms: BSS 4 tablets twice daily (2.1 grams of BSS total) vs placebo. Travellers were included if they were ≥ 18 and < 70 years of age at the time of enrollment, were leaving for an international trip ≥7 days after their pretravel consultation, travelling in country for ≥7 days but ≤ 21 days, and travelling to either Southeast Asia, South Central Asia, North Africa, or Sub-Saharan Africa. Self-completed web-based questionnaires were administered before, during, and after travel.

Results: 270 participants were included. The median age was 32 years (Interquartile range [IQR]: 27-44); 63% were female. Travellers were most frequently White (144; 61%) and non-Hispanic (239; 94%). The most frequent country of travel was Kenya (n = 87; 32%). The median total trip duration was 10 days ([IQR]: 8-13). The most frequent reason for travel was leisure/tourism (230, 85%). There was no significant difference among the groups for symptoms of loose stool and/or diarrhoea, although target sample size was not reached.

Conclusions: This study provides the first new data since the 1980s about the potential use of BSS in the prevention of TD. These data should not be viewed as evidence in isolation because of sample size constraints; further studies are needed to determine if there is a benefit in certain traveller groups or under certain circumstances.

Keywords: Travellers’ diarrhoea; prevention; travel.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of participants and exclusions, 2018–2023. ∗10 (3%) did not have the minimum 7 days in the specified regions; 6 (2%) had < 7 days of travel data; 3 (1%) were duplicate records; 1 (0.4%) had missing screening data; 1 (0.4%) took a disqualifying medication. ∗∗81 participants completed at least one daily during travel questionnaire on paper

References

    1. Connor B Travelers’ diarrhea. In: Nemhauser J (ed). Yellow Book. New York, NY: Oxford University Press, 2024, pp. 85–91.
    1. Carroll SC, Castellanos ME, Stevenson RA, Henning L. Incidence and risk factors for travellers’ diarrhoea among short-term international adult travellers from high-income countries: a systematic review with meta-analysis of cohort studies. J Travel Med 2024; 32:taae008.
    1. Heather CS. Travellers’ diarrhoea. BMJ Clin Evid 2015; 0901.
    1. American Family Physician. Prevention and treatment of Traveler’s Diarrhea. Am Fam Physician 1999;60:119–124. - PubMed
    1. Arcilla MS, Hattem JM, Haverkate MR et al. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis 2017; 17:78–85. - PubMed

Publication types

MeSH terms